Listed by the USPTO as PARKIN, JEFFREY S
Tech Center 1600 • Art Units: 1648 1671
This examiner grants 64% of resolved cases
PARKIN, JEFFREY S works in Tech Center 1600 and Art Unit 1648. The record includes 876 resolved cases, an allowance rate of 63.9%, and an interview lift of 22.2%. The substantial docket shows allowances in a majority of resolved matters and supplies a broad outcome history for practitioners evaluating this examiner.
No leading companies or firms are listed. The available data therefore supports planning based on the examiner's technical assignment, resolved-case volume, allowance outcome, and interview metric, without additional applicant or counsel context.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17745723 | COMPOSITIONS AND METHODS FOR TREATING LONG COVID | Non-Final OA | AIM ImmunoTech Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy63.9% of resolved applications examined by Jeffrey S Parkin were allowed (876 resolved cases), compared with 49.3% across Art Unit 1648 over the last five years.
This examiner's interview lift is +22.2 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Jeffrey S Parkin examines applications in Art Unit 1648 in Tech Center 1600 (Biotechnology & Pharmaceuticals).